09:30 AM EST - Oncolytics Biotech Inc : Today announced that Chief Medical Officer Thomas Heineman, M.D., Ph.D., will participate in the Viral Immunotherapy – Moving Forward panel at Canaccord Genuity's Horizons in Oncology Virtual Conference, which is taking place virtually on April 20, 2023. Oncolytics Biotech Inc
shares T.ONC are trading up $0.03 at $1.55.
